MX342417B - Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. - Google Patents

Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.

Info

Publication number
MX342417B
MX342417B MX2012010520A MX2012010520A MX342417B MX 342417 B MX342417 B MX 342417B MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 342417 B MX342417 B MX 342417B
Authority
MX
Mexico
Prior art keywords
oxidative stress
treatment
antioxidant composition
reducing oxidative
hormonal contraceptive
Prior art date
Application number
MX2012010520A
Other languages
English (en)
Other versions
MX2012010520A (es
Inventor
Umberto Cornelli
Original Assignee
Cor Con Int S R L *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Con Int S R L * filed Critical Cor Con Int S R L *
Publication of MX2012010520A publication Critical patent/MX2012010520A/es
Publication of MX342417B publication Critical patent/MX342417B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una composición antioxidante para reducir el estrés oxidativo en sujetos que se someten a tratamiento con fármaco anticonceptivo hormonal; en particular, dicha composición ha demostrado ser especialmente conveniente ya que, además de ser sorprendentemente efectiva, es extremadamente bien tolerada por el cuerpo ya que contiene componentes naturales tales como catequinas del té verde, levadura de selenio, ácido alfalipoico, y coenzima Q10.
MX2012010520A 2010-03-12 2011-03-11 Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. MX342417B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10425067A EP2364697A1 (en) 2010-03-12 2010-03-12 Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs
PCT/EP2011/053680 WO2011110661A1 (en) 2010-03-12 2011-03-11 Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs

Publications (2)

Publication Number Publication Date
MX2012010520A MX2012010520A (es) 2013-01-18
MX342417B true MX342417B (es) 2016-09-27

Family

ID=42537475

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012010520A MX342417B (es) 2010-03-12 2011-03-11 Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.

Country Status (8)

Country Link
US (1) US20130251696A1 (es)
EP (2) EP2364697A1 (es)
JP (1) JP5852971B2 (es)
CN (1) CN102811714B (es)
AU (1) AU2011226037B2 (es)
ES (1) ES2587255T3 (es)
MX (1) MX342417B (es)
WO (1) WO2011110661A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567695B1 (en) * 2011-09-09 2016-10-26 Cornelli Consulting S.A.S. Di Umberto Cornelli & C. Antioxidant composition for reducing oxidative stress ascribable to treatment with hormonal contraceptives
ITMI20130397A1 (it) 2013-03-15 2014-09-16 Giuliani Spa Composizione a base di flavonidi per uso farmaceutico, nutrizionale o cosmetico con potenziata azione antiossidante
JP6771853B2 (ja) * 2014-03-31 2020-10-21 小林製薬株式会社 ビタミンｂ６含有組成物
RU2563178C1 (ru) * 2014-07-11 2015-09-20 государственное бюджетное образовательное учреждение высшего профессионального образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ТюмГМУ Минздрава России) Способ профилактики оксидативного стресса на фоне применения гормональной контрацептивной рилизинг-системы
CA2965671A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
US20050053560A1 (en) * 2003-09-05 2005-03-10 Pharmaton S.A Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
US20100129467A9 (en) * 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
CN101433314B (zh) * 2007-11-13 2012-05-30 蒋爱芳 一种具有抗疲劳、抗氧化功能的保健食品
WO2009087987A1 (ja) * 2008-01-10 2009-07-16 Nutri Co., Ltd. 高齢者の栄養状態の改善、発熱回数の低下及び/又は免疫能向上のための組成物
GB0802403D0 (en) * 2008-02-08 2008-03-12 Probiox Sa Compositions for the treatment of oxidative stress
CN101569414B (zh) * 2008-04-29 2013-04-10 安琪酵母股份有限公司 一种富含酵母硒和酵母葡聚糖的组合物

Also Published As

Publication number Publication date
JP5852971B2 (ja) 2016-02-03
AU2011226037B2 (en) 2014-11-27
WO2011110661A1 (en) 2011-09-15
EP2544675B1 (en) 2016-06-01
MX2012010520A (es) 2013-01-18
CN102811714B (zh) 2016-08-03
US20130251696A1 (en) 2013-09-26
EP2544675A1 (en) 2013-01-16
AU2011226037A1 (en) 2012-10-11
JP2013522262A (ja) 2013-06-13
ES2587255T3 (es) 2016-10-21
CN102811714A (zh) 2012-12-05
EP2364697A1 (en) 2011-09-14

Similar Documents

Publication Publication Date Title
MX2015008114A (es) Derivados de exendina-4.
GB2491327A (en) Delayed prolonged drug delivery
EP4233545A3 (en) Synergistic bacterial compositions and methods of production and use thereof
GB2491328A (en) Immediate/delayed drug delivery
PH12015500688A1 (en) Exendin-4 derivatives as dual glp1/glucagon agonists
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
WO2010089128A3 (en) Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
WO2011069010A3 (en) Amantadine compositions and methods of use
MX362375B (es) Extracto de saliva entera de sanguijuela.
WO2012142413A3 (en) Nitrite compositions and uses thereof
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX342417B (es) Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.
MX2013011833A (es) Formula infantil para ser usada en la prevencion de enfermedades cardiovasculares.
MX2011011559A (es) Parasiticidas sanguineos.
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
IN2014DN09383A (es)
WO2012105816A3 (ko) 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물
MX336154B (es) Tratamiento de atrofia vaginal en mujeres con riesgo de patologia tumoral.
WO2013188876A3 (en) Methods for modulating kallikrein (klkb1) expression
WO2014031745A3 (en) Materials and methods for modulating glucose uptake
MY159675A (en) Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
RU2012155738A (ru) Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа
RU2012137549A (ru) Композиция внутреннего применения для коррекции гормонального старения кожи
UA56226U (ru) Способ лечения и профилактики послеоперационных рубцов у крыс, прооперированных по поводу нейрохирургической патологии, с использованием электрофореза препарата стекловидное тело
WO2011099721A3 (ko) 수지상 세포의 성숙화 유도용 조성물

Legal Events

Date Code Title Description
FG Grant or registration